<DOC>
	<DOCNO>NCT01156363</DOCNO>
	<brief_summary>This open label , single arm study assess efficacy long-term maintenance haemoglobin level safety tolerability methoxy polyethylene glycol-epoetin beta [ Mircera ] dialysis patient chronic renal anaemia . Patients regular long-term haemodialysis peritoneal dialysis receive monthly subcutaneous intravenous Mircera 6 month . Target sample size &lt; 200 patient .</brief_summary>
	<brief_title>A Study Monthly Subcutaneous Intravenous Mircera Dialysis Patients With Chronic Renal Anaemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>adult patient , &gt; /=18 year age chronic renal anaemia haemoglobin 10.012.0g/dl screen adequate iron status continuous stable ESA ( erythropoietic stimulating agent ) therapy &gt; /= 2 month regular haemodialysis regular peritoneal dialysis &gt; /= 3 month uncontrolled hypertension haemoglobinopathy anaemia due haemolysis pure red cell aplasia ( PRCA )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>